LT-2423

N/A

Report date: 2023/02/18 19:46:42
NME

Base Information

Drug NameLT-2423
Drug Alias NameLT-2423
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Clinical)
Highest Status in ChinaN/A
Originator CompaniesLipicard Technologies
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLipicard Technologies
Active IndicationsN/A
Inactive IndicationsInflammation

Other Information

ATC CodeN/A
Related LinksN/A